-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Reiterates Market Outperform on Nuvation Bio, Maintains $6 Price Target

Benzinga·06/25/2025 13:54:58
Listen to the news
JMP Securities analyst Silvan Tuerkcan reiterates Nuvation Bio (NYSE:NUVB) with a Market Outperform and maintains $6 price target.